News from us and our partners

Tags

Topics

0 results

News
28 February, 2022
Catamaran Bio announces appointment of Michael DeRidder, PhD, as senior vice president, corporate strategy and new product planning
News
24 February, 2022
Women on both sides of the 'pitch call' meet at virtual round table
News
23 February, 2022
"We build them to be great companies," Anne Osdoit tells In Vivo
News
23 February, 2022
Antoine Papiernik discusses Theranos in lively France Culture podcast
News
23 February, 2022
Mnemo Therapeutics names Robert LaCaze as CEO
News
22 February, 2022
EryDel appoints Thomas Sabia as chief commercial officer
News
22 February, 2022
Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia
News
22 February, 2022
Myricx Pharma announces senior team expansion with appointment of CMO and heads of biology and bioinformatics
News
14 February, 2022
Noema Pharma announces FDA Investigational New Drug Authorization for Phase 2b study of trigeminal neuralgia therapy
News
11 February, 2022
ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10
News
7 February, 2022
Elicit Plant raises €16M to accelerate R&D and marketing of its natural solution for the reduction of crop water consumption
News
4 February, 2022
Enthera Pharmaceuticals, Boston Children’s Hospital and the University of Milan reveal use of novel pathway to restore pancreatic cell function in diabetes
News
2 February, 2022
5 Sofinnova Partners portfolio companies selected to French Tech 120
News
1 February, 2022
Is there a lack of European late-stage capital?
News
31 January, 2022
SafeHeal closes €40 million financing co-led by Sofinnova Partners and Genesis MedTech to finance its Colovac device through a pivotal clinical trial in the United States
News
31 January, 2022
Henrijette Richter discusses R&D in plenary at WuXi Global Forum

Catamaran Bio announces appointment of Michael DeRidder, PhD, as senior vice president, corporate strategy and new product planning

Women on both sides of the 'pitch call' meet at virtual round table

"We build them to be great companies," Anne Osdoit tells In Vivo

Antoine Papiernik discusses Theranos in lively France Culture podcast

Mnemo Therapeutics names Robert LaCaze as CEO

EryDel appoints Thomas Sabia as chief commercial officer

Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia

Myricx Pharma announces senior team expansion with appointment of CMO and heads of biology and bioinformatics

Noema Pharma announces FDA Investigational New Drug Authorization for Phase 2b study of trigeminal neuralgia therapy

ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10

Elicit Plant raises €16M to accelerate R&D and marketing of its natural solution for the reduction of crop water consumption

Enthera Pharmaceuticals, Boston Children’s Hospital and the University of Milan reveal use of novel pathway to restore pancreatic cell function in diabetes

5 Sofinnova Partners portfolio companies selected to French Tech 120

Is there a lack of European late-stage capital?

SafeHeal closes €40 million financing co-led by Sofinnova Partners and Genesis MedTech to finance its Colovac device through a pivotal clinical trial in the United States

Henrijette Richter discusses R&D in plenary at WuXi Global Forum